CJ CheilJedang to acquire a majority stake in Batavia Bioscience from FDI and Batavia Biopharma for $229.5m.

CJ CheilJedang, a food and biotechnology company, agreed to acquire a majority stake in Batavia Bioscience, a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from FDI and Batavia Biopharma for $229.5m. "While many global biopharmaceutical companies are actively developing biotechnology products, Batavia is among the very few who are equipped with the facilities and know-how to rapidly and cost-effectively manufacture these products," CJ CheilJedang.